Although insulin is considered to be an anti-atherogenic hormone [5], other studies have suggested that long-term (i.e., chronic) insulin resistance accompanied by hyperinsulinemia contributes to the pathogenesis of atherosclerosis by augmenting the effects of inflammatory cytokines, thereby significantly increasing the expression of CAMs [6-11]. The gene discussed is INS; the disease is hyperinsulinism.